Bernstein US Healthcare Services 2026 Outlook: Could MCOs Be Leaving the Upside Down?
Summaries are public. PDF access requires an active membership; all members have the same access. Sign in
Bernstein anticipates a significant inflection point for US managed care organizations, forecasting the beginning of a multi-year earnings recovery starting in 2026. The report highlights that the operating and policy environment over the past two to three years has been extraordinarily challenging, compressing government business margins and valuations well below historical norms. As competitors exit unprofitable segments and pricing tightens, the sector is positioned for above-normal EPS growth through 2029.
Medicare Advantage margins are expected to show measurable improvement as early as 2026, supported by a robust final revenue rate of 5.00% and disciplined industry pricing. Meanwhile, the Medicaid segment faces a more protracted but ultimately attractive recovery trajectory. The individual market is anticipated to experience rapid margin normalization by 2027, despite anticipated membership pressures in 2026 following the expiration of subsidies.
Utilization trends, which previously accelerated due to labor supply constraints, are projected to decelerate to historical trend lines around 1.5% as wage growth normalizes. Bernstein identifies UnitedHealth Group as its top overall pick to leverage the initial recovery phase, maintaining an Outperform rating with a target price of $444. For investors seeking targeted exposure to the Medicaid recovery, the firm also recommends Centene, Molina Healthcare, and Elevance Health, advising investors to build positions opportunistically following fourth-quarter earnings and guidance releases.